Online citations, reference lists, and bibliographies.
← Back to Search

Insulin Degradation: Progress And Potential.

W. Duckworth, R. Bennett, F. G. Hamel
Published 1998 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.
This paper references
Defective internalization of insulin and its receptor in cells expressing mutated insulin receptors lacking kinase activity.
J. Hari (1987)
Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
J. Semple (1989)
Purification and partial characterization of the liver membrane endopeptidase which transforms glucagon into glucagon (19-29)
P. Blache (1992)
Rabkin R 1989 Retroendocytosis of insulin in a cultured kidney epithelial cell line
Dc Dahl
The time course of insulin degradation in the perifused isolated fat cell
CT Huber (1980)
10.1073/PNAS.89.9.3835
An unusual active site identified in a family of zinc metalloendopeptidases.
A. Becker (1992)
10.1016/0006-291X(86)90579-6
Phytohemagglutinin (PHA) activated human T-lymphocytes: concomitant appearance of insulin binding, degradation and insulin-mediated activation of pyruvate dehydrogenase (PDH).
C. Buffington (1986)
10.2337/diab.29.1.27
Insulin Degradation by Mononuclear Cells
A. Powers (1980)
10.1172/JCI108352
Inhibition of insulin degradation by nonsuppressible insulin-like activity.
G. Burghen (1976)
10.1172/JCI106669
Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme.
A. Kitabchi (1971)
Insulin degrading enzyme ( IDE ) in renal proximal tubules
R Rabkin (1992)
10.1210/ENDO.136.1.7828556
Sequential processing of insulin by cultured kidney cells.
J. Fawcett (1995)
10.1038/325620A0
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon
A. Mallat (1987)
10.1073/PNAS.83.12.4147
Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.
K. Shii (1986)
Insulin degrading enzyme The Handbook of Experimental Pharmacology. olysis by insulin in isolated rat hepatocytes: possible role of internalized hormone
Wc Duckworth (1990)
10.1006/BBRC.1998.8276
Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
W. Duckworth (1998)
Glucocorticoid regulation of chloroquine nonsensitive insulin degradation in cultured fetal rat hepatocytes.
M. Ali (1989)
10.1210/ENDO-129-4-2058
Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells.
Y. Yamaguchi (1991)
10.1111/J.1432-1033.1991.TB16374.X
Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme.
D. Müller (1991)
10.1210/ENDO.132.6.8504733
Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway.
S. Harada (1993)
10.1210/ENDO-123-6-2701
High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line.
W. Duckworth (1988)
10.1210/ENDO-113-4-1525
Inhibition of insulin degradation by insulin-like growth factors.
R. Misbin (1983)
10.1210/JCEM-52-2-177
Insulin degradation in serum of a patient with apparent insulin resistance.
R. Misbin (1981)
10.1210/ENDO-108-4-1142
Insulin degradation by hepatocytes in primary culture.
W. Duckworth (1981)
Functional relationships between insulin binding, action, and degradation. A reassessment.
J. Caro (1980)
10.1089/DNA.1994.13.487
1,10-Phenanthroline increases nuclear accumulation of insulin in response to inhibiting insulin degradation but has a biphasic effect on insulin's ability to increase mRNA levels.
S. Harada (1994)
10.1111/J.1432-1033.1973.TB03010.X
Substrate studies for insulin-specific protease.
F. Baskin (1973)
10.1016/0014-5793(93)81286-9
The rat insulin‐degrading enzyme
H. Baumeister (1993)
Kissebah AH 1986 Splanchnic insulin metabolism in obesity: influence of body fat distribution
An Peiris
10.1042/BJ3200871
Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis.
S. Hurel (1996)
10.1042/BJ3060021
Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
S. Harada (1995)
10.1038/372567A0
A yeast gene necessary for bud-site selection encodes a protein similar to insulin-degrading enzymes
A. Fujita (1994)
10.1152/AJPENDO.1989.257.4.E491
Abnormal insulin metabolism by specific organs from rats with spontaneous hypertension.
C. Mondon (1989)
Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor.
R. Thies (1989)
10.2337/diab.36.4.542
Insulin-Stimulated Glucose Transport and Insulin Internalization Share a Common Postbinding Step in Adipocytes
A. Jochen (1987)
Acquisition of insulin-dependent protein tyrosine kinase activity during Drosophila embryogenesis.
L. Petruzzelli (1985)
10.1152/ajpendo.1997.273.4.E801
Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms.
S. L. Calzi (1997)
Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin.
C. Hofmann (1983)
The inactivation of insulin by tissue extracts. I. The distribution and properties of insulin inactivating extracts (insulinase)
IA Mirsky (1949)
Insulin degrading enzyme (IDE) in renal proximal tubules. Diabetes
R Rabkin (1992)
Information: Dr. G. Copinschi, Laboratory of Experimental Medicine
10.1073/PNAS.91.13.6078
N-arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes.
A. R. Pierotti (1994)
10.1042/BJ2280137
Degradation of endocytosed insulin in rat liver is mediated by low-density vesicles.
R. Pease (1985)
10.1210/ENDO-102-6-1766
Insulin and glucagon binding and degradation by kidney cell membranes.
W. Duckworth (1978)
10.1073/PNAS.85.10.3469
Developmental regulation of an insulin-degrading enzyme from Drosophila melanogaster.
M. Stoppelli (1988)
10.32388/1wkj3p
Insulin-degrading enzyme.
F. Authier (1996)
10.1210/endo.138.8.5344
Insulin-Degrading Enzyme Does Not Require Peroxisomal Localization for Insulin Degradation.
V. Chesneau (1997)
10.1152/ajpendo.1997.273.4.E657
Insulin is degraded extracellularly in wounds by insulin-degrading enzyme (EC 3.4.24.56).
J. D. Shearer (1997)
10.1016/0076-6879(95)48046-3
Insulysin and pitrilysin: insulin-degrading enzymes of mammals and bacteria.
A. Becker (1995)
Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells.
P. Naquet (1987)
10.1016/0003-9861(84)90193-0
Partial purification and characterization of insulin protease and its intracellular inhibitor from rat liver.
R. A. McKenzie (1984)
10.1006/BMMB.1993.1027
Purification of nonantibiotic insulinase inhibitors from bacitracin.
V. Medina (1993)
10.1002/DMR.5610100205
How to measure insulin clearance.
M. Castillo (1994)
10.1152/AJPENDO.1995.268.5.E820
Chloroquine does not exert insulin-like actions on human forearm muscle metabolism.
E. Barrett (1995)
10.1016/S0167-4838(96)00202-6
Identification of the cleavage sites of transforming growth factor alpha by insulin-degrading enzymes.
F. G. Hamel (1997)
10.1042/BJ2770779
Purification of a protease in red blood cells that degrades oxidatively damaged haemoglobin.
J. Fagan (1991)
10.1210/MEND-5-5-734
Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action.
D. McClain (1991)
Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit.
J. Backer (1990)
Degradation products of insulin generated by hepatocytes and by insulin protease.
W. Duckworth (1988)
The insulin and glucagon degrading proteinase of rat liver: a metal-dependent enzyme.
S. Ansorge (1984)
10.1203/00006450-199305001-00097
RECEPTOR ACCESSORY FACTOR (RAF) ENHANCES SPECIFIC DNA BINDING OF ANDROGEN AND GLUCOCORTICOID RECEPTORS
S. Kupfer (1993)
10.2337/diab.36.11.1320
Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects
L. Groop (1987)
10.2337/diab.28.8.746
Insulin Binding and Degradation by Muscles from Streptozotocin-diabetic Rats
W. Duckworth (1979)
10.2337/diab.32.8.705
Receptor Binding Properties of Monoiodotyrosyl Insulin Isomers Purified by High Performance Liquid Chromatography
B. Frank (1983)
Receptor-mediated endocytosis of A 14 - 125 I-insulin by the nonfiltering perfused rat kidney
H Sato (1991)
10.1152/AJPENDO.1994.267.3.E454
Effect of growth hormone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs.
Y. Okuda (1994)
10.1016/0303-7207(90)90142-U
Characterization of insulin degradation products generated in liver endosomes: In vivo and in vitro studies
J. Clot (1990)
10.1021/BI00432A018
Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites.
W. Duckworth (1989)
10.1210/ENDO-114-3-753
Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes.
D. Peavy (1984)
10.1093/INTIMM/4.10.1161
Processing and presentation of insulin. III. Insulin degrading enzyme: a neutral metalloendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for helper T cells.
J. Semple (1992)
10.1093/CVR/28.4.579B
The Biology and Medicine of Signal Transduction.
Ian MacFadzean (1994)
10.1210/ENDO-126-3-1551
Differences in adenosine triphosphate dependency of receptor-mediated endocytosis of alpha 2-macroglobulin and insulin correlate with separate routes of ligand-receptor complex internalization.
R. M. Smith (1990)
10.1152/AJPENDO.1997.272.6.E1089
Fate of insulin analogs in intact and nephrectomized rats determined by their receptor binding constants.
V. Kruse (1997)
10.2337/diab.39.11.1339
Effect of Bacitracin on Retroendocytosis and Degradation of Insulin in Cultured Kidney Epithelial Cell Line
D. C. Dahl (1990)
10.2337/diab.38.2.152
Degradation of Insulin and Insulin-Like Growth Factors by Enzyme Purified From Human Erythrocytes: Comparison of Degradation Products Observed With A14- and B26-[125I]monoiodoinsulin
R. Misbin (1989)
10.2337/diab.46.1.57
Effects of Free Fatty Acids and Glucose on Splanchnic Insulin Dynamics
M. M. Hennes (1997)
10.3109/07435808409035411
Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.
R. Roth (1984)
10.1515/9783111646190-060
Role of the Biodegradation Process in the Action of Insulin. A Proposal for a Model Consisting of Sulfhydryl- Disulfide Interchange Reaction and Proteolysis
P. T. Varandani (1980)
The inactivation of insulin by tissue extracts; the effect of fasting on the insulinase content of rat liver.
Broh-Kahn Rh (1949)
10.1073/PNAS.76.2.635
Initial site of insulin cleavage by insulin protease.
W. Duckworth (1979)
10.1042/BJ3190149
Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells.
F. Authier (1996)
10.2337/diab.28.7.640
Insulin Resistance Caused by Massive Degradation of Subcutaneous Insulin
E. Paulsen (1979)
DUCKWORTH, BENNETT, AND HAMEL Vol
JL Carpentier (1993)
Adipose tissue extraction of circulating insulin in anaesthetized Zucker obese rats.
A. Ardévol (1996)
Internalized insulin-receptor complexes are unidirectionally translocated to chloroquine-sensitive degradative sites. Dependence on metabolic energy.
P. Berhanu (1988)
10.1021/BI00217A014
Purification and properties of a membrane-bound insulin binding protein, a putative receptor, from Neurospora crassa.
H. K. Kole (1991)
10.1016/0006-291X(90)90539-Y
Natural regulatory mechanisms of insulin degradation by insulin degrading enzyme.
H. Akiyama (1990)
10.1111/J.1432-1033.1985.TB09283.X
Studies on the formation of intrachain disulphide bonds in newly biosynthesised bovine prolactin. Role of protein-disulphide isomerase.
M. Kaderbhai (1985)
10.1016/0006-291X(83)90400-X
Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease.
M. Ryan (1983)
10.2337/diab.39.5.570
Free–Fatty Acid Inhibition of Insulin Binding, Degradation, and Action in Isolated Rat Hepatocytes
J. Svedberg (1990)
10.1128/MCB.16.5.2509
The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis.
L. Yenush (1996)
10.1111/j.1365-2362.1972.tb00669.x
Release of Immunoreactive Insulin from the Human Heart
M. Wahlqvist (1972)
Degradation of Alzheimer's 622
J R Mcdermott (1997)
Identification of glutamate-169 as the October, 1998 INSULIN DEGRADATION 621 third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes
AB Becker (1993)
10.1006/BBRC.1997.6693
Insulin inhibition of proteasome activity in intact cells.
F. G. Hamel (1997)
10.1042/BJ2490215
Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase.
L. Savoy (1988)
10.1126/SCIENCE.2451860
Stimulation of RNA and protein synthesis by intracellular insulin.
D. Miller (1988)
10.1128/JB.163.3.1055-1059.1985
Physical characterization of the cloned protease III gene from Escherichia coli K-12.
C. Dykstra (1985)
10.1152/AJPRENAL.1992.262.5.F813
Time course and kinetics of proximal tubular processing of insulin.
S. Nielsen (1992)
10.1042/BJ2900205
Evolutionary families of peptidases.
N. Rawlings (1993)
Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
W. Duckworth (1990)
10.1073/PNAS.69.7.1681
Sequential degradation of insulin by rat liver homogenates.
P. T. Varandani (1972)
10.1042/BJ2750389
Homologues of insulinase, a new superfamily of metalloendopeptidases.
N. Rawlings (1991)
10.1016/0006-291X(86)90329-3
Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes.
M. Pell (1986)
10.2337/diab.28.9.810
Insulin-degrading Activity of Plasma Membranes from Rat Skeletal Muscle: Its Isolation, Characterization, and Biologic Significance
K. Yokono (1979)
Modulation of kidney cell protein degradation by insulin.
T. Tsao (1990)
10.1016/0003-9861(92)90662-G
Characterization and partial purification of an insulinase from Neurospora crassa.
H. K. Kole (1992)
Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
W. Ogawa (1992)
10.1016/0092-8674(89)90043-3
Protein disulfide isomerase: Multiple roles in the modification of nascent secretory proteins
R. B. Freedman (1989)
10.1152/AJPCELL.1988.255.1.C70
Uptake and intracellular fate of [14C]sucrose-insulin in perfused rat livers.
C. A. Surmacz (1988)
10.1007/978-1-4612-4502-5_3
Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide.
P. A. Ward (1988)
10.1021/BI00485A022
Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme.
J. Affholter (1990)
10.1126/science.270.5235.464
Role of Yeast Insulin-Degrading Enzyme Homologs in Propheromone Processing and Bud Site Selection
N. Adames (1995)
Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
H. Chen (1993)
Posthepatic rate third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes
T Morishima (1992)
In search of the subcutaneous insulin degradation syndrome
DS Schade (1986)
10.1007/978-1-4612-4502-5_3
Receptor-mediated endocytosis and intracellular processing of insulin: ultrastructural and biochemical evidence for cell-specific heterogeneity and distinction from nonhormonal ligands.
R. M. Smith (1988)
Alemany M 1995 Rat insulin turnover in vivo
X Canas
10.1152/AJPENDO.1981.241.3.E251
Insulin binding, internalization, and receptor regulation in cultured human fibroblasts.
D. Baldwin (1981)
10.1002/EJI.1830250430
Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice
D. Daniel (1995)
10.1021/BI00355A046
Differential and analytical subfractionation of rat liver components internalizing insulin and prolactin.
J. Bergeron (1986)
10.1152/PHYSREV.1995.75.3.473
Pathophysiology of insulin resistance in human disease.
G. Reaven (1995)
10.1021/BI00160A026
Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry.
D. Müller (1992)
10.1152/AJPENDO.1992.263.4.E772
Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state.
Toyohiko Morishima (1992)
10.1002/JCB.240440303
Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin‐degrading enzyme are inhibited by the same metalloendoprotease inhibitors
C. Kayalar (1990)
Increasing understanding of calmodulin-insulin interactions.
W. Duckworth (1994)
10.1016/S0026-0495(97)90153-0
Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
L. Monti (1997)
Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme.
K. Shii (1985)
A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase.
W. Duckworth (1994)
10.2337/diab.39.6.683
Partial Characterization of Mechanism of Insulin Accumulation in H35 Hepatoma Cell Nuclei
R. M. Smith (1990)
Cellular and endosomal degradation
WC Duckworth (1990)
Initial site of cleavage of insulin by insulin protease
WC Duckworth (1979)
10.2337/diab.38.12.1579
Defects in Insulin-Receptor Internalization and Processing in Monocytes of Obese Subjects and Obese NIDDM Patients
V. Trischitta (1989)
10.2337/diab.46.2.197
Characterization of the Insulin Inhibition of the Peptidolytic Activities of the Insulin-Degrading Enzyme–Proteasome Complex
R. Bennett (1997)
Identification of zinc ligands of the insulin-degrading enzyme.
R. K. Perlman (1994)
Androgen and glucocorticoid receptors interact with insulin degrading enzyme.
S. Kupfer (1994)
Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.
D. Peavy (1985)
10.1210/en.138.8.3444
Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation.
V. Chesneau (1997)
Insulin inhibition of fatty acid b-oxidation in isolated peroxisomes. Diabetes
RG Bennett (1996)
10.1016/S0303-7207(96)03981-0
Intraendosomal degradation of transforming growth factor alpha
F. G. Hamel (1997)
10.1016/0006-291X(87)90975-2
Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes.
W. Duckworth (1987)
10.1083/JCB.105.1.449
Characterization of a Drosophila protein that binds both epidermal growth factor and insulin-related growth factors
J. V. Garcia (1987)
10.1210/ENDO-111-4-1102
Identification of insulin-degrading enzyme on the surface of cultured human lymphocytes, rat hepatoma cells, and primary cultures of rat hepatocytes.
K. Yokono (1982)
10.1023/A:1016241610649
Insulin-Degrading Enzyme in a Human Colon Adenocarcinoma Cell Line (Caco-2)
J. P. Bai (2004)
10.1159/000173196
Renal uptake and degradation of trapped-label insulin.
J. Hysing (1989)
10.1210/EDRV-9-3-319
Insulin degradation: mechanisms, products, and significance.
W. Duckworth (1988)
10.1016/0006-291X(91)92094-Z
Identification of the metal associated with the insulin degrading enzyme.
A. Ebrahim (1991)
10.1172/JCI110082
Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats.
J. Philippe (1981)
10.1172/JCI117103
Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors.
C. Bondy (1994)
10.1016/S0041-1345(96)00457-5
Autoimmune islet damage mediated by insulin-specific T cells.
M. Crawford (1997)
10.1016/0026-0495(90)90041-A
[125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
F. Williams (1990)
10.1016/0014-5793(94)00387-4
Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme
I. V. Kurochkin (1994)
Purification and partial characterization of the liver membrane endopeptidase which transforms glucagon into glucagon
P Blache (1992)
Studies on the formation of interchain disulfide bonds in newly synthesized bovine prolactin
MA Kaderbhai (1985)
10.1210/ENDO-115-2-591
The degradation of monoiodotyrosyl insulin isomers by insulin protease.
M. Ryan (1984)
10.1073/PNAS.86.17.6640
Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells.
A. Soler (1989)
10.1210/JCEM-64-1-162
Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women.
A. Peiris (1987)
10.1152/AJPENDO.1981.240.3.E325
Evidence for modulation of insulin action and degradation independently of insulin binding.
J. Caro (1981)
10.1073/PNAS.87.9.3358
The insulin receptor with phenylalanine replacing tyrosine-1146 provides evidence for separate signals regulating cellular metabolism and growth.
P. Wilden (1990)
Effect of the insulin degradation inhibitors bacitracin and chloroquine on insulin binding data to H35 rat hepatoma cells.
C. D. de Vries (1990)
10.1152/AJPENDO.1993.265.1.E162
Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM.
R. Hovorka (1993)
10.1210/MEND-5-10-1467
Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
W. Kuo (1991)
10.1042/BJ2920137
Identification of glutamate-169 as the third zinc-binding residue in proteinase III, a member of the family of insulin-degrading enzymes.
A. Becker (1993)
10.2337/diab.46.1.3
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
G. Boden (1997)
Renal metabolism of peptide hormones.
R. Rabkin (1983)
10.2337/diab.40.4.436
Degradation of Intraendosomal Insulin by Insulin-Degrading Enzyme Without Acidification
F. G. Hamel (1991)
Insulin inhibition of fatty acid ␤-oxidation in isolated peroxisomes
R G Bennett (1996)
Degradation of Alzheimer’s 622 DUCKWORTH, BENNETT, AND HAMEL Vol. 19, No. 5 b-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme
JR McDermott (1997)
10.1210/ENDO-108-5-1821
Electron microscope autoradiographic analysis of [125I]iodoinsulin entry into adult rat hepatocytes in vivo: evidence for multiple sites of hormone localization.
I. Goldfine (1981)
10.1210/ENDO-104-6-1758
Insulin degradation by liver cell membranes.
W. Duckworth (1979)
10.1007/BF03346945
Further evidence that insulin metabolism is a major determinant of peripheral insulin response to oral glucose in subjects with mild glucose intolerance
E. Bonora (1986)
10.1016/S0074-7696(08)62479-1
Insulin internalization and other signaling pathways in the pleiotropic effects of insulin.
R. Smith (1997)
Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.
F. Stentz (1989)
Alzheimer’s b-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme
IV Kurochkin (1994)
Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line.
W. Kuo (1994)
Insulin and glucagon binding and degradation by the kidney cell membrane
WC Duckworth (1978)
Increased clearance and degradation of 3 H insulin in streptozotocin diabetic rats: role of the insulin-receptor compartment
J Philippe (1981)
10.2337/diab.33.1.64
Degradation of Insulin by Isolated Mouse Pancreatic Acini: Evidence for Cell Surface Protease Activity
I. Goldfine (1984)
10.1210/EDRV-16-2-117
Insulin action and the insulin signaling network.
B. Cheatham (1995)
10.1210/ENDO.133.4.8404592
Degradation of insulin by isolated rat renal cortical endosomes.
J. Fawcett (1993)
10.1002/JCP.1041530323
Nonreceptor mediated nuclear accumulation of insulin in H35 rat hepatoma cells
S. Harada (1992)
Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon.
P. Blache (1993)
10.1016/0167-4889(86)90149-7
The reversible receptor binding of insulin in isolated rat adipocytes measured at 37 degrees C. The binding is not rate limiting for cellular uptake.
O. Sonne (1986)
10.1073/PNAS.82.24.8443
Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin.
K. L. Thompson (1985)
10.1210/ENDO-120-2-829
In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.
J. Hari (1987)
Stimulation of protein synthesis in stage IV Xenopus oocytes by microinjected insulin.
D. Miller (1989)
10.1172/JCI112758
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
A. Peiris (1986)
Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.
F. Authier (1994)
Purification and characterization of protease III from Escherichia coli.
Y. Cheng (1979)
10.2337/diacare.8.1.12
The Etiology of Incapacitating, Brittle Diabetes
D. Schade (1985)
Minireview: protein disulfide isomerase
R Noiva (1992)
10.1210/ENDO.136.9.7649094
Rat insulin turnover in vivo.
X. Cañas (1995)
10.1002/JCB.240480104
Substrates and signalling complexes: The tortured path to insulin action
R. Roth (1992)
10.1006/JAUT.1994.1066
Analysis of the spontaneous T cell response to insulin in NOD mice.
D. Wegmann (1994)
10.1073/PNAS.93.2.956
Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).
D. Daniel (1996)
10.1002/JCP.1041470315
Stimulation of protein synthesis by internalized insulin
D. Miller (1991)
10.1152/AJPCELL.1989.257.2.C190
Retroendocytosis of insulin in a cultured kidney epithelial cell line.
D. C. Dahl (1989)
10.1042/BJ2490209
Identification of radioactive insulin fragments liberated by insulin proteinase during the degradation of semisynthetic [3H]GlyA1]insulin and [3H]PheB1]insulin.
J. G. Davies. (1988)
10.1210/MEND-4-8-1125
Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.
J. Affholter (1990)
10.1210/ENDO-117-4-1693
The calcium dependence of insulin degradation by rat skeletal muscle.
M. Ryan (1985)
10.1210/EDRV-2-2-210
Insulin metabolism and degradation.
W. Duckworth (1981)
10.1007/s001250051393
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor
D. Ish-Shalom (1997)
10.1042/BJ3200947
The characterization of endosomal insulin degradation intermediates and their sequence of production.
P. Seabright (1996)
10.1083/JCB.122.6.1243
Two steps of insulin receptor internalization depend on different domains of the beta-subunit [published erratum appears in J Cell Biol 1993 Nov;123(4):1047]
J. Carpentier (1993)
Functional analysis of conserved residues in the active site of insulin-degrading enzyme.
R. K. Perlman (1993)
High performance liquid chromatographic analysis of insulin degradation products from isolated hepatocytes: effects of inhibitors suggest intracellular and extracellular pathways
FG Hamel (1987)
Insulin acts intracellulary on proteasomes through insulin-degrading enzyme
WC Duckworth (1998)
␤-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme
Increasing understanding of calmodulin-insulin interactions.
D. Wc (1994)
10.2337/diab.36.6.702
HPLC Analysis of Insulin Degradation Products From Isolated Hepatocytes: Effects of Inhibitors Suggest Intracellular and Extracellular Pathways
F. G. Hamel (1987)
Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes. Possible role of internalized hormone.
B. Draznin (1982)
10.2337/diab.43.2.297
Insulin Degradation In Vitro and In Vivo: A Comparative Study in Men: Evidence That Immunoprecipitable, Partially Rebindable Degradation Products Are Released From Cells and Circulate in Blood
L. Benzi (1994)
10.1016/0026-0495(83)90004-5
Decreased hepatic insulin extraction in subjects with mild glucose intolerance.
E. Bonora (1983)
The significance of intracellular insulin to insulin action.
W. Duckworth (1997)
Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III.
L. Ding (1992)
Intranuclear localization of insulin in rat hepatoma cells: insulin/matrix association.
K. A. Thompson (1989)
High performance liquid chromatographic analysis of insulin degradation products from perfused rat kidney
WC Duckworth (1989)
Identification of radioactive insulin fragments liberated during the degradation of semisynthetic [3H]Gly insulin and [3H]Phe insulin
JG Davies (1988)
Insulin degradation: assays and enzymes
MP Ryan (1988)
Protein disulfide isomerase. A multifunctional protein resident in the lumen of the endoplasmic reticulum.
R. Noiva (1992)
10.1002/JOBM.3620350107
A periplasmic insulin‐cleaving proteinase (ICP) from Acinetobacter calcoaceticus sharing properties with protease III from Escherichia coli and IDE from eucaryotes
B. Fricke (1995)
10.1016/0009-8981(89)90369-0
Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis.
S. Antoniello (1989)
10.1083/JCB.108.1.177
An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity
J. V. Garcia (1989)
10.1152/AJPREGU.1996.270.3.R682
Effect of lactate on hepatic insulin clearance in perfused rat liver.
C. Pagano (1996)
10.1210/ENDO-120-2-450
The effect of insulin concentration on retroendocytosis in isolated rat adipocytes.
J. Levy (1987)
10.1016/0006-291X(87)90472-4
Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
A. Jochen (1987)
10.1042/BJ2400609
Identification of some cleavage sites of insulin by insulin proteinase.
J. G. Davies. (1986)
10.1210/ENDO-116-3-926
Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts.
F. Stentz (1985)
Isolation of insulin degradation products from endosomes derived from intact rat liver.
F. G. Hamel (1988)
10.1016/0026-0495(84)90164-1
Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women.
D. Evans (1984)
10.1126/science.7809629
A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules
M. Kovacsovics-Bankowski (1995)
Mutations in a zinc-binding domain of human insulin-degrading enzyme eliminate catalytic activity but not insulin binding.
B. D. Gehm (1993)
10.1097/00006676-199001000-00003
Proteolytic Degradation of Human Recombinant Proinsulin/Insulin by Sera from Acute Pancreatitis Patients and Complete Inhibition by Eglin‐C
P. Lau (1990)
10.1172/JCI109689
Time-course of insulin degradation in perifused isolated rat adipose cells.
C. T. Huber (1980)
Insulin inhibition of fatty acid boxidation in isolated peroxisomes
RG Bennett (1996)
Insulin resistance due to massive destruction of subcutaneous insulin
EP Paulsen (1979)
10.1016/0304-4165(91)90213-Z
Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney.
H. Sato (1991)
10.1210/JCEM.77.5.8077319
Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.
M. Letiexhe (1993)
10.1152/AJPENDO.1993.264.3.E342
Female sex hormones, perinatal, and peripubertal androgenization on hepatocyte insulin dynamics in rats.
G. Krakower (1993)
10.1021/BI960582Q
Identification of γ-Endorphin-Generating Enzyme as Insulin-Degrading Enzyme†
A. Safavi (1996)
10.1210/ENDO.137.7.8770881
Insulin signaling network -- waiting for Copernicus.
B. Draznin (1996)
10.1021/BI00526A012
Role of disulfide interchange enzyme in immunoglobulin synthesis.
R. Roth (1981)
10.1073/PNAS.92.9.3859
Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase.
F. Authier (1995)
10.1021/BI00412A006
Isolation and characterization of an insulin-degrading enzyme from Drosophila melanogaster.
J. V. Garcia (1988)
10.1016/0006-291X(88)90436-6
Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
K. Yonezawa (1988)
10.1159/000474989
Insulin-degrading activity in experimental liver cirrhosis of the rat.
M. Auletta (1994)
10.1016/S0026-0495(96)90027-X
Glyburide increases the secretion, tissue uptake, and action of insulin in conscious normal dogs.
H. Adrogué (1996)
Identification of g endorphin-generating enzyme as insulin-degrading enzyme
A Safavi (1996)
Inhibition of intracellular prote October, 1998 INSULIN DEGRADATION 623 olysis by insulin in isolated rat hepatocytes: possible role of internalized hormone
B Draznin (1982)
Endocrinologie First announcement: The 42 nd Journées Internationales d'Endocrinologie Clinique will be held in Paris on April 29 -30, 1999 and will be devoted to: "Hormones, heart and vessels
10.1210/JCEM.82.6.3979
Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
C. N. Jones (1997)
10.1006/BBRC.1997.6066
Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling.
K. Seta (1997)
10.1210/ENDO.132.2.7678795
Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
W. Kuo (1993)
10.1038/KI.1979.148
Effect of prolonged uremia on insulin metabolism by isolated liver and muscle.
R. Rabkin (1979)
10.1016/0006-291X(82)91871-X
Selective antilipolytic effect of bacitracin in the isolated fat cell.
C. Heckemeyer (1982)
10.2337/diacare.8.1.5
A Clinical Algorithm to Determine the Etiology of Brittle Diabetes
D. Schade (1985)
10.2337/diab.34.5.446
Effects of Lysosomal Inhibitors on 125I-Insulin and 125I-Asialofetuin Degradation by the Isolated, Perfused Rat Liver and Isolated Rat Hepatocytes
W. Ward (1985)
10.1111/j.1600-065X.1988.tb00780.x
Pathways of Processing of Insulin by Antigen‐Presenting Cells
Terry L. Delovitch (1988)
10.2337/diab.23.6.536
Insulin and Glucagon Degradation by the Same Enzyme
W. Duckworth (1974)
The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells.
J. Backer (1990)
INSULIN DEGRADATION olysis by insulin in isolated rat hepatocytes: possible role of internalized hormone
October (1998)
10.1056/NEJM198607173150302
In search of the subcutaneous-insulin-resistance syndrome.
D. Schade (1986)
Van Der Veen EA 1990 Effect of the insulin degradation inhibitors bacitracin and chloroquine on insulin binding data to H35 rat hepatoma cells
Cp De Vries
Reaven GM 1997 Alterations in the glucose-stimulated insulin secretory doseresponse curve and in insulin clearance in nondiabetic insulinresistant individuals
Cn Jones
10.1006/BBRC.1994.2034
Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase.
R. Bennett (1994)
10.1002/JCP.1041410311
Kinetics of insulin internalization and processing in adipocytes: Effects of insulin concentration
A. Jochen (1989)
10.1126/SCIENCE.3059494
Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III.
J. Affholter (1988)
10.1210/ENDO-128-3-1603
Regulation of insulin, epidermal growth factor, and transforming growth factor-alpha levels by growth factor-degrading enzymes.
B. D. Gehm (1991)
10.1016/0002-9343(88)90399-3
Hepatic metabolism of insulin.
W. Duckworth (1988)
10.1210/ENDO-118-1-328
High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
F. G. Hamel (1986)
10.1073/PNAS.84.2.459
Ultrastructural evidence for the accumulation of insulin in nuclei of intact 3T3-L1 adipocytes by an insulin-receptor mediated process.
R. M. Smith (1987)



This paper is referenced by
10.1016/j.neuron.2004.08.024
Clearance of Alzheimer's Aβ Peptide The Many Roads to Perdition
R. Tanzi (2004)
NATRIURETIC PEPTIDES MODULATE HEART RATE, ELECTRICAL CONDUCTION AND ARRHYTHMOGENSIS IN VIVO
Kimberly M Vella (2013)
10.1016/S1043-2760(02)00608-2
Regulation of insulin action by CEACAM1
S. Najjar (2002)
10.1042/BJ20041081
Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria.
M. Leissring (2004)
10.2460/AJVR.2005.66.1907
Effects of short- and long-term recombinant equine growth hormone and short-term hydrocortisone administration on tissue sensitivity to insulin in horses.
E. de Graaf-Roelfsema (2005)
10.1016/B978-0-12-385471-1.00005-2
Effects of Renal Disease on Pharmacokinetics
A. Atkinson (2007)
CEACAM1: A Common Regulator of Fat Metabolism and Cell Proliferation
Sang Jun Lee (2008)
10.1016/J.DIABRES.2007.08.017
Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population.
S. H. Kwak (2008)
10.1016/j.brainresbull.2008.02.027
Long-term effects of intracerebroventricular insulin microinjection on renal sodium handling and arterial blood pressure in rats
L. F. Menegon (2008)
10.1254/FPJ.132.181
新規持効型溶解インスリンアナログ注射製剤インスリン デテミル(レベミル®)の薬理学的特徴および臨床試験成績
泰之 片山 (2008)
10.1016/j.bbrc.2009.04.047
PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
J. Du (2009)
A role for CEACAM2 in insulin homeostasis and action
Payal R. Patel (2010)
10.17169/REFUBIUM-7245
Role of gastrointestinal hormones in the metabolic dysfunction in obesity and associated diseases
N. Rudovich (2011)
10.1371/journal.pone.0031787
Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme
Bilal Cakir (2012)
10.1161/ATVBAHA.108.172320
Deficiency and Inhibition of Cathepsin K Reduce Body Weight Gain and Increase Glucose Metabolism in Mice
M. Yang (2008)
10.1021/acs.jcim.8b00406
Catalytic Mechanism of Amyloid-β Peptide Degradation by Insulin Degrading Enzyme: Insights from QM/MM MP2 Calculation
Rui Lai (2019)
10.1073/pnas.1005704107
Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus
S. Gupta (2010)
10.1007/978-4-431-55763-0_19
Catabolism and Anabolism of Amyloid-β
S. Hashimoto (2015)
10.1002/jcp.27667
Hyperinsulinemia is associated with increasing insulin secretion but not with decreasing insulin clearance in an age‐related metabolic dysfunction mice model
Mirian A Kurauti (2019)
10.1152/ajpendo.00519.2018
Assessment of pulsatile insulin secretion derived from peripheral plasma C-peptide concentrations by nonparametric stochastic deconvolution.
Marcello C. Laurenti (2019)
10.1515/revneuro-2014-0025
Deciphering an interplay of proteins associated with amyloid β 1-42 peptide and molecular mechanisms of Alzheimer’s disease
L. F. Hernández-Zimbrón (2014)
10.1111/j.1749-6632.2008.03782.x
Degradation of Relaxin Family Peptides by Insulin‐Degrading Enzyme
R. Bennett (2009)
10.1002/ajmg.b.30186
Association studies between risk for late‐onset Alzheimer's disease and variants in insulin degrading enzyme
P. Nowotny (2005)
10.1210/JCEM.86.2.7137
Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus.
C. Homko (2001)
10.1210/EN.2003-0543
Endosomal proteolysis of glucagon at neutral pH generates the bioactive degradation product miniglucagon-(19-29).
F. Authier (2003)
10.1046/J.1365-313X.2003.01904.X
Characterization of a novel zinc metalloprotease involved in degrading targeting peptides in mitochondria and chloroplasts.
P. Moberg (2003)
Fettsäure-induzierte Apoptose: Die Bedeutung der Toll-like Rezeptoren 2 und 4 in insulinsezernierenden Zellen
Abteilung für Innere Medizin (2010)
10.1203/PDR.0b013e3181da463a
In Vitro and In Vivo Effect of Acylated and Unacylated Ghrelin on Neonatal Glucose Homeostasis
Hehong Ni (2010)
10.1177/2042018813501188
Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?
F. Kulozik (2013)
A diabetes minimal model for oral glucose tolerance tests
J. Andrés Christen (2016)
10.1093/HMG/9.14.2149
Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.
H. Fakhrai-rad (2000)
10.1007/s00018-011-0658-x
Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes
N. Vigneron (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar